Petmed Express Inc (NASDAQ:PETS) was the recipient of unusually large options trading activity on Thursday. Traders acquired 963 put options on the company. This represents an increase of approximately 783% compared to the typical daily volume of 109 put options.

Shares of NASDAQ PETS opened at $36.80 on Friday. The firm has a market cap of $749.02 million, a price-to-earnings ratio of 20.08 and a beta of 0.54. Petmed Express has a 52-week low of $31.81 and a 52-week high of $57.80.

Petmed Express (NASDAQ:PETS) last issued its quarterly earnings data on Monday, July 23rd. The company reported $0.62 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.63 by ($0.01). The company had revenue of $87.39 million for the quarter, compared to the consensus estimate of $85.72 million. Petmed Express had a net margin of 14.42% and a return on equity of 35.77%. The firm’s revenue was up 9.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.45 earnings per share. equities research analysts anticipate that Petmed Express will post 2.28 EPS for the current year.

A number of equities research analysts have weighed in on PETS shares. BidaskClub upgraded shares of Petmed Express from a “sell” rating to a “hold” rating in a research note on Friday, May 25th. CL King started coverage on shares of Petmed Express in a research note on Friday, June 15th. They set a “neutral” rating on the stock. Craig Hallum reiterated a “sell” rating and set a $32.00 price target (down previously from $38.00) on shares of Petmed Express in a research note on Monday, July 9th. ValuEngine downgraded shares of Petmed Express from a “sell” rating to a “strong sell” rating in a research note on Tuesday, July 10th. Finally, Zacks Investment Research downgraded shares of Petmed Express from a “buy” rating to a “hold” rating in a research note on Tuesday, July 10th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. Petmed Express presently has an average rating of “Hold” and a consensus target price of $36.75.

In other Petmed Express news, Director Robert C. Schweitzer sold 7,500 shares of Petmed Express stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $37.00, for a total transaction of $277,500.00. Following the sale, the director now owns 88,334 shares in the company, valued at $3,268,358. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 3.70% of the stock is owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of PETS. Redwood Investments LLC bought a new position in shares of Petmed Express during the first quarter valued at $13,425,000. Brown Advisory Inc. bought a new position in shares of Petmed Express during the first quarter valued at $401,000. Xact Kapitalforvaltning AB bought a new position in shares of Petmed Express during the second quarter valued at $242,000. Bank of Montreal Can lifted its holdings in shares of Petmed Express by 46.4% during the second quarter. Bank of Montreal Can now owns 16,689 shares of the company’s stock valued at $735,000 after acquiring an additional 5,292 shares during the period. Finally, Scout Investments Inc. bought a new position in shares of Petmed Express during the second quarter valued at $3,563,000. 95.68% of the stock is owned by institutional investors.

About Petmed Express

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Further Reading: Should you buy a closed-end mutual fund?

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.